These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1200 related items for PubMed ID: 17207233

  • 41. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A.
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [Abstract] [Full Text] [Related]

  • 42. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?
    Hourfar MK, Walch LA, Geusendam G, Dengler T, Janetzko K, Gubbe K, Frank K, Karl A, Löhr M, Sireis W, Seifried E, Schmidt M.
    Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K.
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [Abstract] [Full Text] [Related]

  • 46. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z, Milani S, Sharifi Z.
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [Abstract] [Full Text] [Related]

  • 47. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen.
    Walz A, Wirth S, Hucke J, Gerner P.
    J Infect Dis; 2009 Oct 15; 200(8):1227-31. PubMed ID: 19751152
    [Abstract] [Full Text] [Related]

  • 48. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
    Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Koidl C, Kessler HH.
    J Clin Virol; 2004 Apr 15; 29(4):221-3. PubMed ID: 15018848
    [Abstract] [Full Text] [Related]

  • 49. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.
    Liver Transpl; 2001 Jun 15; 7(6):513-7. PubMed ID: 11443579
    [Abstract] [Full Text] [Related]

  • 50. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.
    Transfusion; 2007 Oct 15; 47(10):1803-8. PubMed ID: 17880604
    [Abstract] [Full Text] [Related]

  • 51. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct 15; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 52. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr 15; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 53. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 15; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 54. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A.
    J Med Virol; 2009 May 15; 81(5):815-25. PubMed ID: 19319945
    [Abstract] [Full Text] [Related]

  • 55. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 15; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 56. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C.
    J Infect Dis; 2005 May 01; 191(9):1435-41. PubMed ID: 15809901
    [Abstract] [Full Text] [Related]

  • 57. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran.
    Khamesipour A, Amiri ZM, Kafiabad SA, Saadat F, Mansour-ghanaei F, Esteghamati AR, Shakib RJ.
    Transfus Apher Sci; 2011 Oct 01; 45(2):195-7. PubMed ID: 21971311
    [Abstract] [Full Text] [Related]

  • 58. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.
    Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS.
    J Hepatol; 2006 Jan 01; 44(1):39-46. PubMed ID: 16168517
    [Abstract] [Full Text] [Related]

  • 59. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.
    J Gastroenterol Hepatol; 2008 Nov 01; 23(11):1710-5. PubMed ID: 18761556
    [Abstract] [Full Text] [Related]

  • 60. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.
    N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.